drugset / Trial / NCT05830695

Evaluation of Apexogenesis With Human Treated Dentin Matrix in Young Permanent Molars

NCT05830695

Phase 1/2 Completed 20 enrolled nora mostafa mohammed abo shanady
RandomizedParallel-groupSingle-blindTreatment

Summary

Assess the clinical, radiographic, and tomographic outcomes of apexogenesis with human treated dentin matrix in young permanent molars compared to MTA.

Timeline

Start
2022-01-18
Primary completion
2022-07-18
Completion
2023-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Mineral Trioxide Aggregate Other / unclassified
Subject human treated dentin matrix Unknown

Indications